Skip to main content
OpenTrials
Completed

NCT Number: NCT01472159

Can Glucose Monitoring Improve (CGMi Study)

The purpose of this 2-year randomized controlled trial (RCT) is to implement and evaluate a family-focused behavioral teamwork intervention aimed at overcoming barriers to sustained continuous glucose monitoring (CGM) use in youth with type 1 diabetes (T1D). We hypothesize that CGM implemented with a family-focused, behavioral teamwork intervention will result in sustained CGM use and greater improvement in A1c compared to routine implementation of CGM.

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Joslin Diabetes Center

Boston, Massachusetts, 02215, United States

About this study

Consistent CGM use in youth with T1D has been difficult to sustain historically. Youth with T1D and their families have routinely felt burden related to the introduction of this technology into their care management. Additionally, there can be difficulties with calibration, skin irritation, frequent skips, excessive or nuisance alarms and inaccurate readings which often lead to diminished use or discontinuation entirely. The purpose of this protocol is to implement and evaluate a family-focused behavioral teamwork intervention aimed at overcoming barriers to sustained CGM use in youth with T1D. In this 2-year RCT, we will assess the long-term acceptability and durability of CGM use and its associated glycemic and psychological outcomes in youth with T1D and their families. We will randomize 120 families to one of two groups: (1) CGM implemented according to usual care (CGM-Usual Care, CGM-UC) or (2) CGM implemented with a family teamwork intervention (CGM-Teamwork, CGM-TW). This intervention will allow participants and families to overcome barriers to sustained CGM use and achieve glycemic benefits that have been afforded to adults using CGM as demonstrated in other research. In year 1, all CGM supplies will be provided and covered by study resources. In year 2, study participants will be asked to cover the costs associated with sensor use and any costs associated with replacement of CGM components in a manner consistent with routine clinical care as the investigators believe that it is important to assess durability of CGM use in clinical practice.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 8-17 years
  • Planning to be living at home for 2 years
  • Type 1 diabetes of at least 1 year duration
  • Daily insulin dose ≥0.5 units/kg
  • A1c ≥6.5% and ≤10.0%
  • Insulin therapy with continuous subcutaneous insulin infusion (CSII) or multiple daily injections (≥3 injections/day)
  • Blood glucose (BG) monitoring frequency ≥4 times/day
  • Agreement to wear a CGM device
  • Fluency in English for child and parent/guardian
  • Stable living situation for ≥6 months (e.g., no Department of Youth Services Involvement)
  • Joslin Clinic attendance: At least one Joslin Clinic visit in last year AND Anticipated care at Joslin Clinic for duration of study

Exclusion criteria

  • Consistent CGM use, defined as 6+ days/week during the previous 6 months
  • History of severe, life-threatening skin reactions to the adhesive used with the CGM device
  • Pregnancy in the youth participant or intention to become pregnant within the next 2 years
  • Significant developmental or cognitive disorder in the youth or parent/guardian that would prevent full participation in a family-based, behavioral intervention or implementation of CGM
  • Inpatient psychiatric admission within the previous 6 months
  • Participation in another intervention study during the previous 3 months
  • Intent to enroll in another intervention study during the study period

Treatment and study plan

CGM Family Teamwork Intervention

Behavioral

The family-focused behavioral intervention targets barriers associated with sustained CGM use in youth with type 1 diabetes. During months 1-18, families in the intervention group will participate in the intervention at each study visit for about an additional 30 minutes.

Primary outcomes

  1. Change in glycemic control, assessed by hemoglobin A1c

    Time frame: Baseline and 1 year

Secondary outcomes

  1. Change in psychosocial factors (e.g., self-efficacy, fear of hypoglycemia, quality of life, diabetes-specific family conflict, diabetes responsibility sharing, diabetes-specific burden, anxiety, depressive symptoms)

    Time frame: Baseline and 1 year

  2. Change in glycemic control, assessed by hemoglobin A1c

    Time frame: 1 year and 2 years

    Durability of the intervention will be assessed by change in A1c from 1 year to 2 years

  3. Change in psychosocial factors (e.g., self-efficacy, fear of hypoglycemia, quality of life, diabetes-specific family conflict, diabetes responsibility sharing, diabetes-specific burden, anxiety, depressive symptoms)

    Time frame: 1 year and 2 years

Sponsors and collaborators

Lead sponsor

Joslin Diabetes Center

Other

Collaborators

  • Jaeb Center for Health Research
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registry information

Official study title

Optimizing CGM Use and Metabolic Outcomes in Youth With Type 1 Diabetes

Important dates

Study start
2011
Primary completion
2014
Study completion
2015
First posted
Nov 16, 2011
Registry last updated
Aug 10, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.